Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W Hunt

Showing results (191-200 of 342) with videos related to

Pageof 35
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|April 12, 2019
High Incidence of Intended Partner Pregnancy Among Men Living With HIV in Rural Uganda: Implications for Safer Conception ServicesAngela Kaida, Jerome Kabakyenga, Mwebesa Bwana, et al.
AIDS (London, England)|February 26, 2013
Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infectionPatrick Unemori, Kieron S Leslie, Peter W Hunt, et al.
The Journal of Infectious Diseases|May 6, 2014
Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatmentAllan R Tenorio, Yu Zheng, Ronald J Bosch, et al.
AIDS Research and Human Retroviruses|June 25, 2014
Prevalence and virologic consequences of transmitted HIV-1 drug resistance in UgandaGuinevere Q Lee, David R Bangsberg, Conrad Muzoora, et al.
The Journal of Antimicrobial Chemotherapy|January 30, 2025
Subtypes A1 and D, and recombinant HIV-1 natural polymorphisms associated with lenacapavir drug resistance in UgandaDaniel Omoding, Nicholas Musinguzi, Yap Boum, et al.
Plos One|February 10, 2011
A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllersPeter W Hunt, Alan L Landay, Elizabeth Sinclair, et al.
Contraception|May 19, 2015
The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural UgandaChristina I Nieves, Angela Kaida, George R Seage, et al.
Journal of Virology|April 21, 2017
Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease ProgressionMarion W Kiguoya, Jaclyn K Mann, Denis Chopera, et al.
AIDS (London, England)|April 19, 2016
Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected UgandansSulggi A Lee, Joel A Mefford, Yong Huang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2009
Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatmentColleen F Kelley, Christina M R Kitchen, Peter W Hunt, et al.
Pageof 35

Showing results (191-200 of 342) with videos related to

Sort By:
Pageof 35
Journal of Acquired Immune Deficiency Syndromes (1999)|April 12, 2019
High Incidence of Intended Partner Pregnancy Among Men Living With HIV in Rural Uganda: Implications for Safer Conception ServicesAngela Kaida, Jerome Kabakyenga, Mwebesa Bwana, et al.
AIDS (London, England)|February 26, 2013
Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infectionPatrick Unemori, Kieron S Leslie, Peter W Hunt, et al.
The Journal of Infectious Diseases|May 6, 2014
Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatmentAllan R Tenorio, Yu Zheng, Ronald J Bosch, et al.
AIDS Research and Human Retroviruses|June 25, 2014
Prevalence and virologic consequences of transmitted HIV-1 drug resistance in UgandaGuinevere Q Lee, David R Bangsberg, Conrad Muzoora, et al.
The Journal of Antimicrobial Chemotherapy|January 30, 2025
Subtypes A1 and D, and recombinant HIV-1 natural polymorphisms associated with lenacapavir drug resistance in UgandaDaniel Omoding, Nicholas Musinguzi, Yap Boum, et al.
Plos One|February 10, 2011
A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllersPeter W Hunt, Alan L Landay, Elizabeth Sinclair, et al.
Contraception|May 19, 2015
The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural UgandaChristina I Nieves, Angela Kaida, George R Seage, et al.
Journal of Virology|April 21, 2017
Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease ProgressionMarion W Kiguoya, Jaclyn K Mann, Denis Chopera, et al.
AIDS (London, England)|April 19, 2016
Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected UgandansSulggi A Lee, Joel A Mefford, Yong Huang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2009
Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatmentColleen F Kelley, Christina M R Kitchen, Peter W Hunt, et al.
Pageof 35